Virgin Australia is set to make a comeback to the Australian Securities Exchange (ASX) after delisting in 2020, according to the Australian Financial Review. The airline, now owned by private equity giant Bain Capital, plans to relist after achieving a turnaround in profitability during fiscal year 2023.
Executives from Australia’s second-largest airline are scheduled to meet with potential investors on Tuesday, highlighting improved financial performance and a streamlined business model. Virgin Australia had entered voluntary administration in 2020 as the COVID-19 pandemic battered the aviation industry, leading to its acquisition by Bain Capital.
Newly appointed CEO Dave Emerson, who took over from Jayne Hrdlicka this month, will begin a non-deal roadshow this week. Emerson is expected to present the airline’s strategic reset and simplified operations to institutional investors and fund managers. Sources familiar with the matter told AFR that the company is positioning itself as a leaner, more efficient carrier, a key selling point for its potential relisting.
Bain Capital has reportedly been considering re-floating Virgin Australia since the company returned to profitability, and the timing now appears favorable. The upcoming investor meetings are seen as a key step in gauging market interest ahead of a possible IPO.
When contacted, Virgin Australia redirected inquiries to Bain Capital, which has yet to comment publicly on the listing plans.
Virgin Australia’s return to the ASX would mark a significant milestone in its post-pandemic recovery and a potential win for Bain Capital, which could seek to capitalize on renewed investor confidence in the aviation sector. The move also signals growing optimism in Australia’s airline industry amid rising travel demand.


Samsung Electronics Posts Eightfold Profit Surge Driven by AI Chip Demand
Deere & Company Agrees to $99 Million Settlement Over Right-to-Repair Dispute
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
UAE's Largest Natural Gas Facility Suspended After Attack-Triggered Fire
Microsoft's $10 Billion Japan Investment: AI Infrastructure and Data Sovereignty Push
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
UPS and Teamsters Reach Agreement to Limit Driver Severance Program
First Western Ship Transits Strait of Hormuz Since Iran War Began
Britain Courts Anthropic Amid US Defense Department Dispute
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit 



